Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.37 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.37 |
| ▸ | NAAA | Q02083 | 4/20 | 0.32 |
| ▸ | TOP2A | P11388 | 1/20 | 0.32 |
| ▸ | EDNRA | P25101 | 1/20 | 0.31 |
| ▸ | PREP | P48147 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TACR1 | P25103 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13191513 | 0.84 | CRHBP (0.41) | CRHBPCRHR2NAAAEDNRAMAPT | |
| SCHEMBL13170498 | 0.81 | CRHBP (0.44) | CRHBPCRHR2EDNRA | |
| SCHEMBL3799755 | 0.77 | CRHBP (0.35) | CRHBPCRHR2TOP2AMAPTHPGD | |
| SCHEMBL8017542 | 0.77 | CRHBP (0.50) | CRHBPCRHR2MAPT | |
| SCHEMBL8017540 | 0.77 | CRHBP (0.50) | CRHBPCRHR2MAPT | |
| SCHEMBL8023972 | 0.77 | CRHBP (0.50) | CRHBPCRHR2MAPT | |
| SCHEMBL8017544 | 0.77 | CRHBP (0.50) | CRHBPCRHR2MAPT | |
| SCHEMBL3799785 | 0.73 | PREP (0.43) | NAAAPREPTACR1 | |
| SCHEMBL3796502 | 0.68 | IDO1 (0.39) | NAAAPREPTACR1 | |
| SCHEMBL1315036 | 0.66 | IDO1 (0.46) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100222432-A1 | Synthetic Carbon Nanotubes | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222432-A1 | Synthetic Carbon Nanotubes | CYCS, CHN2, TUBA3C | CRHBP 1545/4885CRHR2 2699/4885NAAA 3128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.